Adding hormone therapy to postoperative radiotherapy did not improve OS for most patients ...

CLEVELAND — A groundbreaking randomized clinical trial led by Chair of Radiation Oncology Daniel Spratt at University ...

An ultrasound-based treatment for prostate cancer showed better safety and operative metrics versus robotic radical ...

Pfizer Inc. PFE shares are up during Thursday’s trading session after the company shared data from Talzenna plus Xtandi’s investigational treatment regimen for HRR gene-mutated metastatic ...

HKSH Medical Group (HKSH) today announced the results of Asia's first clinical study on early-stage prostate cancer patients receiving five-session of proton therapy.* The results show significant ...

Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...

Proton therapy may reduce urinary, bowel and sexual side effects in prostate cancer by minimizing radiation exposure to healthy tissue, per Dr. Curtiland Deville Jr. Newer radiation technologies, such ...

UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...

Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.

The 2026 European Association of Urology (EAU) annual meeting featured an advancing prognostics and therapeutics in ...